Medroxyprogesterone Acetate vs LNG-IUS in Early-stage Endometrioid Carcinoma and Atypical Hyperplasia Patients

NCT05565573 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

148

Enrollment

OTHER

Sponsor class

Conditions

Fertility Sparing

Interventions

DRUG: Medroxyprogesterone Acetate 500 MG Oral Tablet
DEVICE: Levonorgestrel-Releasing Intrauterine System

Sponsor

Hua Li